Procutase versus 1% silver sulphadiazine in the treatment of minor burns.

Abstract The purpose of this randomised comparative study was to evaluate the use of silver sulphadiazine (SSD) 1% cream (Group A) with the use of Procutase ® (Group B) in treating burns with a TBSA ® is an ionic hydrogel composed of natural hydrophilic polymers in an active ionic solution with an inhibitor of matrix metalloproteinases MMP-1, -3 and -9 (collagenase/gelatinase). Subjects were seen in follow-up biweekly, and wounds of patients in SSD group were compared with those of Procutase ® group for healing time, pain score at dressing change, compliance with therapy and complication rate. The result of this study showed that Procutase ® treated patients had statistically significantly less pain and shorter wound healing time. Procutase ® can be used successfully in patients with burns that do not require hospital admission.